Chronic Kidney Disease
Conditions
Interventions
None listed
Sponsors
Nihon University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Chronic kidney disease (CKD) who received multidisciplinary care in Japan between January 2015 to December 2020, and patients with CKD receiving intervention by continuous multidisciplinary care and kidney function data available for 12 months before and after receiving multidisciplinary care.
Exclusion criteria
Exclusion criteria: Exclusion criteria were age less than 20 years, eGFR more than 60mL/min/1.73m2, active cancer, transplant recipients and patients who previously have undergone chronic dialysis, and missing data on age, gender, or kidney function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy endpoint was the annual decline in eGFR (changes in eGFR) between before 12 months and after 24 months intervention by multidisciplinary care. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints included annual changes in urinary protein levels between before 12 months and after 24 months intervention by multidisciplinary care, and composite outcome, including all-cause mortality and initiation of renal replacement therapy. | — |
Countries
Japan
Contacts
Public ContactMasanori Abe
Nihon University Itabashi Hospital Division of Nephrology, Hypertension and Endocrinology, Department of Medicine
Outcome results
None listed